Cargando…
Correction to: Azithromycin has enhanced effects on lung fibroblasts from idiopathic pulmonary fibrosis (IPF) patients compared to controls
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6986083/ https://www.ncbi.nlm.nih.gov/pubmed/31992294 http://dx.doi.org/10.1186/s12931-020-1304-7 |
| _version_ | 1783491912044380160 |
|---|---|
| author | Krempaska, Kristina Barnowski, Sandra Gavini, Jacopo Hobi, Nina Ebener, Simone Simillion, Cedric Stokes, Andrea Schliep, Ronja Knudsen, Lars Geiser, Thomas K. Funke-Chambour, Manuela |
| author_facet | Krempaska, Kristina Barnowski, Sandra Gavini, Jacopo Hobi, Nina Ebener, Simone Simillion, Cedric Stokes, Andrea Schliep, Ronja Knudsen, Lars Geiser, Thomas K. Funke-Chambour, Manuela |
| author_sort | Krempaska, Kristina |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6986083 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-69860832020-01-30 Correction to: Azithromycin has enhanced effects on lung fibroblasts from idiopathic pulmonary fibrosis (IPF) patients compared to controls Krempaska, Kristina Barnowski, Sandra Gavini, Jacopo Hobi, Nina Ebener, Simone Simillion, Cedric Stokes, Andrea Schliep, Ronja Knudsen, Lars Geiser, Thomas K. Funke-Chambour, Manuela Respir Res Correction BioMed Central 2020-01-28 2020 /pmc/articles/PMC6986083/ /pubmed/31992294 http://dx.doi.org/10.1186/s12931-020-1304-7 Text en © The Author(s). 2020 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Correction Krempaska, Kristina Barnowski, Sandra Gavini, Jacopo Hobi, Nina Ebener, Simone Simillion, Cedric Stokes, Andrea Schliep, Ronja Knudsen, Lars Geiser, Thomas K. Funke-Chambour, Manuela Correction to: Azithromycin has enhanced effects on lung fibroblasts from idiopathic pulmonary fibrosis (IPF) patients compared to controls |
| title | Correction to: Azithromycin has enhanced effects on lung fibroblasts from idiopathic pulmonary fibrosis (IPF) patients compared to controls |
| title_full | Correction to: Azithromycin has enhanced effects on lung fibroblasts from idiopathic pulmonary fibrosis (IPF) patients compared to controls |
| title_fullStr | Correction to: Azithromycin has enhanced effects on lung fibroblasts from idiopathic pulmonary fibrosis (IPF) patients compared to controls |
| title_full_unstemmed | Correction to: Azithromycin has enhanced effects on lung fibroblasts from idiopathic pulmonary fibrosis (IPF) patients compared to controls |
| title_short | Correction to: Azithromycin has enhanced effects on lung fibroblasts from idiopathic pulmonary fibrosis (IPF) patients compared to controls |
| title_sort | correction to: azithromycin has enhanced effects on lung fibroblasts from idiopathic pulmonary fibrosis (ipf) patients compared to controls |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6986083/ https://www.ncbi.nlm.nih.gov/pubmed/31992294 http://dx.doi.org/10.1186/s12931-020-1304-7 |
| work_keys_str_mv | AT krempaskakristina correctiontoazithromycinhasenhancedeffectsonlungfibroblastsfromidiopathicpulmonaryfibrosisipfpatientscomparedtocontrols AT barnowskisandra correctiontoazithromycinhasenhancedeffectsonlungfibroblastsfromidiopathicpulmonaryfibrosisipfpatientscomparedtocontrols AT gavinijacopo correctiontoazithromycinhasenhancedeffectsonlungfibroblastsfromidiopathicpulmonaryfibrosisipfpatientscomparedtocontrols AT hobinina correctiontoazithromycinhasenhancedeffectsonlungfibroblastsfromidiopathicpulmonaryfibrosisipfpatientscomparedtocontrols AT ebenersimone correctiontoazithromycinhasenhancedeffectsonlungfibroblastsfromidiopathicpulmonaryfibrosisipfpatientscomparedtocontrols AT simillioncedric correctiontoazithromycinhasenhancedeffectsonlungfibroblastsfromidiopathicpulmonaryfibrosisipfpatientscomparedtocontrols AT stokesandrea correctiontoazithromycinhasenhancedeffectsonlungfibroblastsfromidiopathicpulmonaryfibrosisipfpatientscomparedtocontrols AT schliepronja correctiontoazithromycinhasenhancedeffectsonlungfibroblastsfromidiopathicpulmonaryfibrosisipfpatientscomparedtocontrols AT knudsenlars correctiontoazithromycinhasenhancedeffectsonlungfibroblastsfromidiopathicpulmonaryfibrosisipfpatientscomparedtocontrols AT geiserthomask correctiontoazithromycinhasenhancedeffectsonlungfibroblastsfromidiopathicpulmonaryfibrosisipfpatientscomparedtocontrols AT funkechambourmanuela correctiontoazithromycinhasenhancedeffectsonlungfibroblastsfromidiopathicpulmonaryfibrosisipfpatientscomparedtocontrols |